Cemiplimab

ATC L01FF06 · 9 markets · 14 records

Cemiplimab 9 markets · 14 records Forms

AU 3 records · 3 strengths

  • 350 mg/7 mLinjectionLIBTAYO also in US·GB·FR
  • 350 mginjectionLIBTAYO cemiplimab 350 mg concentrate for solution for infusion unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 2 records · 2 strengths

  • 350 mg/7 mLinjectionManufacturer: Catalent Indiana, LLC also in AU·GB·FR
  • 50 mginjectionLIBTAYO

GB 1 records · 1 strengths

  • 350 mg/7 mLinjectionLibtayo 350mg/7ml concentrate for solution for infusion vials also in AU·US·FR

CA 1 records · 1 strengths

ES 1 records · 1 strengths

MX 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

    TW 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名Libtayo concentrate for solution for infusion ×1力汰瘤濃縮輸注液 ×1

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        FR 1 records · 1 strengths

        • 350 mg/7 mLinjectionLIBTAYO 350 mg, solution à diluer pour perfusion also in AU·US·GB
        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.